cagrilintide semaglutide combination phase 3 2024 Cagrilintide–semaglutide (CagriSema) as an add-on to basal insulin in adults with type 2 diabetes (REIMAGINE 3): a randomised, double-blind, placebo-controlled, multicentre, study Cagrilintide–semaglutide (CagriSema) versus semaglutide or

GLP-1 receptor agonists are contraindicated in patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2

Travel scenarios and early dosing Travel is the number one reason people consider taking their GLP-1 injection early

Semaglutide patients should include high-quality protein sources like lean meats, fish, eggs, dairy products, and nuts in their diets

A lot of the evidence supporting this risk comes from case reports, when a doctor writes about a specific patients experience, not large-scale clinical trials

Start by washing your hands, and end by throwing away the used items the right way